Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer - No Study Results Posted

Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)

This study is currently recruiting participants.

Study NCT01395017 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.

First Received: July 8, 2011 Last Updated: April 9, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2014
Estimated Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)